首页> 外文期刊>Journal of Hainan Medical University >Effect of low-rTMS in combined with edaravone on the inflammatory cytokines and cerebral metabolites in patients with cerebral infarction and aphasia
【24h】

Effect of low-rTMS in combined with edaravone on the inflammatory cytokines and cerebral metabolites in patients with cerebral infarction and aphasia

机译:低rTMS联合依达拉奉对脑梗死和失语症患者炎性细胞因子和脑代谢产物的影响

获取原文
           

摘要

Objective: To explore the effect of low-repetitive transcranial magnetic stimulation (low-rTMS)in combined with edaravone on the inflammatory cytokines and cerebral metabolites in patientswith cerebral infarction and aphasia. Methods: A total of 70 patients with acute cerebralinfarction (ACI) and motor aphasia who were admitted in our hospital from March, 2015 toMarch, 2016 were included in the study and randomized into the observation group and thecontrol group, 35 in each group. The patients in the control group were given blood pressurereduction, intracranial pressure reduction, blood lipid regulation, anti-platelet aggregation,symptomatic and supportive treatments, edaravone (30 mg) + normal saline (100 mL), ivdrip,2 times/d, continuously for 2 weeks. On this basis, the patients in the observation group weregiven additional rTMS, continuously for 10 d. Hs-CRP, IL-6, IL-8, and TNF-α levels beforetreatment, 1 week and 2 weeks after treatment in the two groups were detected. MRS was usedto detect NAA and Cho in Broca district before treatment, 1 week and 2 weeks after treatmentin the two groups. ABC was used to evaluate the linguistic function before treatment, 2 weeks,3 months, and 6 months in the two groups. Results: Hs-CRP, IL-6, IL-8, and TNF-α levels 1week and 2 weeks after treatment in the observation group were significantly lower than thosein the control group (P0.05). NAA value on the left side 1 week and 2 weeks after treatmentin the observation group was significantly higher than that in the control group (P0.05), whileCho value was significantly lower than that in the control group (P0.05). ABC score 2 weeks,3 months, and 6 months after treatment in the observation group was significantly higher thanthat in the control group (P0.05). Conclusions: Edaravone in combined with low-rTMS in thetreatment of ACI can effectively inhibit the inflammatory reaction, improve the neurologicaldeficit degree, and promote the recovery of cortex language neural network.
机译:目的:探讨低重复经颅磁刺激(low-rTMS)联合依达拉奉对脑梗死和失语症患者炎性细胞因子和脑代谢产物的影响。方法:将2015年3月至2016年3月在我院收治的急性脑梗死(ACI)和运动性失语症患者70例纳入研究,随机分为观察组和对照组,每组35例。对照组患者给予降压,颅内压降低,血脂调节,抗血小板聚集,对症和支持治疗,依达拉奉(30 mg)+生理盐水(100 mL),ivdrip,2次/ d,连续2个礼拜。在此基础上,连续10 d给予观察组患者额外的rTMS。检测两组治疗前,治疗后1周和2周的Hs-CRP,IL-6,IL-8和TNF-α水平。两组分别在治疗前,治疗后1周和2周用MRS检测Broca区的NAA和Cho。两组分别在治疗前,2周,3个月和6个月时用ABC评估语言功能。结果:观察组治疗1周和2周后Hs-CRP,IL-6,IL-8和TNF-α水平明显低于对照组(P <0.05)。观察组治疗后第1周和第2周左侧NAA值显着高于对照组(P <0.05),而Cho值显着低于对照组(P <0.05)。观察组治疗后2周,3个月和6个月ABC评分明显高于对照组(P <0.05)。结论:依达拉奉联合低剂量rTMS治疗ACI可有效抑制炎症反应,提高神经功能缺损程度,促进皮质语言神经网络的恢复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号